{"canonical":"https://abierto.us/vendors/institut-de-formulation-des-vaccins-ch-sa-n773kszmja78","key":"N773KSZMJA78","name":"INSTITUT DE FORMULATION DES VACCINS (CH) SA","uei":"N773KSZMJA78","city":"PLAN-LES-OUATES","state":null,"awards":2,"obligated":"8308093.07","notices_won":1,"top_agency_name":"National Institutes of Health","top_naics":"541512","cage":"SMVP9","parent_name":"INSTITUT DE FORMULATION DES VACCINS (CH) SA","also_known_as":[],"country":"CHE","actions":9,"first_action":"2024-06-25","last_action":"2026-09-14","breakdowns":{"naics":[{"key":"541512","name":null,"awards":1,"obligated":"6744317.07"},{"key":"541714","name":null,"awards":1,"obligated":"1563776.00"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":2,"obligated":"8308093.07"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":2,"obligated":"8308093.07"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":2,"obligated":"8308093.07"}],"product_service_codes":[{"key":"AN12","name":null,"awards":2,"obligated":"8308093.07"}]},"awards_list":[{"award_key":"CONT_AWD_75N93023C00048_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N93023C00048_7529_-NONE-_-NONE-/","piid":"75N93023C00048","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"N773KSZMJA78","recipient_name":"INSTITUT DE FORMULATION DES VACCINS (CH) SA","recipient_uei":"N773KSZMJA78","recipient_cage":"SMVP9","recipient_city":"PLAN-LES-OUATES","recipient_state":null,"sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2024-06-25","last_action_date":"2026-09-14","actions":6,"obligated":"6744317.07","current_total_value":"8193365.07","potential_total_value":"8193365.07","naics":"541512","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":24,"description":"ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N93024C00021_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N93024C00021_7529_-NONE-_-NONE-/","piid":"75N93024C00021","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"N773KSZMJA78","recipient_name":"INSTITUT DE FORMULATION DES VACCINS (CH) SA","recipient_uei":"N773KSZMJA78","recipient_cage":"SMVP9","recipient_city":"PLAN-LES-OUATES","recipient_state":null,"sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2024-09-19","last_action_date":"2025-04-15","actions":3,"obligated":"1563776.00","current_total_value":"1563776.00","potential_total_value":"9189961.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":13,"description":"VACCINE ADJUVANT DISCOVERY PROGRAM","method":null,"confidence":null,"evidence":null,"opportunity_key":"BAADAIT75N93022R00022","opportunity_title":"VACCINE ADJUVANT DISCOVERY PROGRAM"}],"awards_total":2,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}